Navigation Links
Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data,at Society Of Nuclear Medicine 2007 Annual Meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 4, 2007 - Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that the company will present the results of several preclinical studies at the 54th annual meeting of the Society of Nuclear Medicine (SNM) in Washington, D.C. The presentations include data on Azedra(TM) (Ultratrace (131)I-MIBG), the company's clinical-stage, targeted radiotherapeutic candidate for the treatment of malignant neuroendocrine tumors; Zemiva, its lead molecular imaging pharmaceutical for imaging cardiac ischemia; and MIP-190, its molecular imaging pharmaceutical candidate that targets angiotensin converting enzyme for the detection of heart failure and vascular inflammatory disease. Data on the company's radiolabeled small molecule molecular imaging pharmaceutical, MIP-1072, for the detection and staging of prostate cancer, were presented on June 3rd. -0-
Abstract Title: Formulation comparisons and pharmacokinetics of high

                specific activity Ultratrace 131I-Iobenguane (mIBG)

                for therapy


Authors:        J. F. Kronauge(a1), J. A. Barrett(1), J. Qi(1),

                H. Mok(1), D. H. Hunter(2), C. Bensimon(4),

                S. Oelsner(4), J. P. Norenberg(3), T. Anderson(3),

                S. Gallo(1), S. M. Hiller(1), J. Joyal(1),

                N. S. Lee(1) and J. W. Babich(1);

                1. Molecular Insight Pharmaceuticals, Inc., Cambridge,

                Massachusetts; 2. University of Western Ontario,

                London, Ontario, Canada; 3. University of New Mexico,

                Albuquerque, New Mexico and 4. MDS Nordion, Kanata,

                Ontario, Canada.


Reference #:    335357


Publication No.: 1316 - Scientific Poster Session


Poster Section:  Dosimetry/Radiobiology Posters


Session Info:   "Meet the Author" II: Neurosciences, General Clinical

                Specialties, and Radiopharmaceutical Chemistry Posters

                Monday, June 4

    
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
2. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
3. Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria
4. DNA Therapeutics Reports a Novel Mechanism of Action and a Biomarker of its Lead Molecule Dbait That Open an Innovative Pathway-Targeting in Molecular Cancer Therapy
5. Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimers Disease Presented at AD/PD Meeting
6. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
7. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:9/29/2014)... AMBLER, Pa. , Sept. 29, 2014 /PRNewswire/ ... approval for the CNS Monitor, a medical device ... patients. The CE Mark certifies that a product ... in Europe . ... parameters including electroencephalography (EEG, or brain waves) to ...
(Date:9/29/2014)... , Sept. 29, 2014  Volcano Corporation ... focused on improving patient and economic outcomes on ... minimally invasive coronary and peripheral visualization, physiology diagnostics ... to its Board of Directors from Engaged Capital, ... response:  Volcano welcomes the perspectives ...
(Date:9/29/2014)... NEW YORK , Sept. 29, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "EU5 Sigmoidoscopes Market ... the EU5 Sigmoidoscopes market. The report provides value, ... and average prices (in US dollars) within market ... (Rigid Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
Breaking Medicine Technology:Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3
... NASHVILLE, Tenn., Aug. 4, 2011 Cumberland Pharmaceuticals Inc. ... has executed a new senior credit agreement with Bank of ... its revolving line of credit to $10 million, which is ... the new facility has been extended to December 2014. ...
... Purdue Pharma, L.P., a privately held pharmaceutical ... International , a U.S.-based humanitarian organization that helps ... view the multimedia assets associated with this release, ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM46982 ) Purdue ...
Cached Medicine Technology:Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 3
(Date:9/29/2014)... (PRWEB) September 30, 2014 Top10BestSEOHosting.com ... and reviews about hosting products. It is headed ... rich experience. The site offers research-based information and ... and suppliers in the current market. , ... and announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) and ...
(Date:9/29/2014)... LA (PRWEB) September 29, 2014 ... mission is to provide students with a certification ... awareness necessary to enhance their own lives, and ... Fitness Professionals also benefits the community at large, ... service focused on the professional practice of fitness, ...
(Date:9/29/2014)... September 29, 2014 Each year over ... to complaints of dizziness and imbalance. Symptoms of vestibular ... next and the population range can vary as much ... people will be seeking medical assistance for dizziness and ... from combat with post blast or post concussion injuries ...
(Date:9/29/2014)... Thousand Oaks, Calif. (PRWEB) September 29, 2014 ... and Injury Relief (PMIR) and Thousand Oaks Surgery Center ... Serra Medical Plaza, a state-of-the-art healthcare facility in Thousand ... to these two practices that offer Conejo Valley residents ... patients with acute and chronic pain, while TOSC physicians ...
(Date:9/29/2014)... The specialists from LunaDress always prides themselves on their ... of the price. To benefit more ladies, LunaDress often ... its online store. Today, the company has happily launched ... party dresses . The company’s sales manager says that ... , "We are excited to announce the new ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Narconon Louisiana New Life Retreat Announces Stephen Mogavero Now Certified as a Personal Trainer 2Health News:North American Seminars Received PT Continuing Education Course Approval in California and Nevada and Illinois for an Online Vestibular Continuing Education Course 2Health News:New Thousand Oaks Medical Facility Hosts Grand Opening Event: Two Practices, One Celebration 2Health News:New Thousand Oaks Medical Facility Hosts Grand Opening Event: Two Practices, One Celebration 3Health News:At The Beginning Of Autumn, LunaDress Provides Huge Deals On Its Cocktail Party Dresses 2
... Thought-Leader Joins Senior Management Team, NASHVILLE, Tenn., ... of revenue cycle management and clinical communication,solutions, announced ... Senior,Vice President of Corporate Strategy, effective immediately., ... the business of healthcare,and health information technology. Most ...
... 20 Shamir Optical,Industry Ltd. (Nasdaq: SHMR ) ... on Wednesday, May 28, 2008, and has scheduled a,conference ... that morning., The conference call will be broadcast ... to http://www.kcsa.com approximately ten minutes before the,conference ...
... to be widely available for chronic pain sufferers., ... Pharma, Inc.,(Other OTC:INNP.PK - News) is pleased to ... to the Natural Pain Relief Center,non-narcotic proprietary breakthrough ... one in five Americans suffer with chronic pain ...
... to treat patients with latent tuberculosis (TB), who are infected ... less than half the time and at a lower cost ... a multi-center, randomized controlled trial. The results will be presented ... on Tuesday, May 20. , We found that using ...
... 20 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :,HAE), ... plasma-derived protein products for commercialization,announces that Gilles ... Finance at the Montreal Sheraton Centre on ... Busines$ Meets Finance, Busines$ Meets Finance ...
... Health IT Solutions Recognized, BOSTON, May 20 ... TEPR Awards honorees during the Opening Session of,the ... Conference in,Ft. Lauderdale, Florida., TEPR Awards annually ... and solutions. The 2008 TEPR Awards honorees,are:, ...
Cached Medicine News:Health News:Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy 2Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing First Quarter 2008 Earnings Results 2Health News:Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment 2Health News:Rifampin: Latent TB treatment saves time money and lives 2Health News:Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre 2Health News:2008 TEPR Awards Honorees Announced 2
... Total Knee System provides the adaptability surgeons ... patient. Not the other way around. The ... inserts and patellar components allow surgeons to ... you do it all with one instrument ...
... new implant. It's a new material, exclusively ... can be greatly reduced . The nickel ... of the nickel-sensitive patient. Hardness, lubricity and ... is available in our two already proven ...
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
Cementless hip system...
Medicine Products: